Villanova Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Buy
70,491
+7,710
+12% +$278K 2.19% 16
2026
Q1
$2.22M Sell
62,781
-7,874
-11% -$320K 2.27% 12
2025
Q4
$2.87M Buy
70,655
+11,906
+20% +$518K 2.02% 13
2025
Q3
$2.76M Buy
+58,749
New +$3.05M 1.91% 16

Other funds holding CNMD

Villanova Investment Management's CNMD Position: Q2 2026 in Review

Villanova Investment Management increased its CONMED (CNMD) stake by 12% in Q2 2026, buying an estimated $278K and bringing the position to 70,491 shares worth $2.31M. The position accounts for 2.19% of the portfolio, ranked #16.

Villanova Investment Management first reported a position in CNMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.87M in Q4 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Villanova Investment Management held 70,491 shares of CONMED worth $2.31M as of Q2 2026.
  • Villanova Investment Management bought 7,710 CONMED shares in Q2 2026, an estimated $278K.
  • CONMED made up 2.19% of Villanova Investment Management's portfolio in Q2 2026, its #16 holding.
  • Villanova Investment Management first reported a position in CONMED in Q3 2025 and has held it in 4 quarters since.
  • Villanova Investment Management's CONMED position peaked at $2.87M in Q4 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Villanova Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.